Philip Insel

Doktorand
Fler filtreringsmöjligheter
  1. Cross-validation of optimized composites for preclinical Alzheimer's disease

    Donohue, M. C., Sun, C. K., Raman, R., Philip S. Insel & Aisen, P. S., 2017 jan 1, I : Alzheimer's and Dementia: Translational Research and Clinical Interventions. 3, 1, s. 123-129 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression

    Alzheimer's Disease Neuroimaging Initiative, 2017, I : American Journal of Geriatric Psychiatry. 25, 9, s. 980-991

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment

    Gonzales, M. M., Philip S. Insel, Nelson, C., Tosun, D., Michael Schöll, Niklas Mattsson, Sacuiu, S., Bickford, D., Weiner, M. W., Mackin, R. S. & The Alzheimer's Disease Neuroimaging Initiative, 2018, I : International Journal of Geriatric Psychiatry. 33, 10, s. 1305-1311 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

    Philip S. Insel, Niklas Mattsson, Mackin, R. S., Michael Schöll, Nosheny, R. L., Tosun, D., Donohue, M. C., Aisen, P. S., Jagust, W. J. & Weiner, M. W., 2016 maj 17, I : Neurology. 86, 20, s. 1887-1896 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

    Philip S. Insel, Donohue, M. C., Mackin, R. S., Aisen, P. S., Oskar Hansson, Weiner, M. W. & Niklas Mattsson, 2016 dec, I : Neurobiology of Aging. 48, s. 172-181 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition: Evidence for emerging amyloid pathology in alzheimer's disease

    Philip S. Insel, Ossenkoppele, R., Gessert, D., Jagust, W. J., Landau, S. M., Oskar Hansson, Weiner, M. W., Niklas Mattsson & Alzheimer's Disease Neuroimaging Initiative, 2017 maj 17, I : Frontiers in Neuroscience. 11, MAY, 281.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Amyloid pathology in the progression to mild cognitive impairment

    Philip S. Insel, Oskar Hansson, Mackin, R. S., Weiner, M., Niklas Mattsson & Alzheimer's Disease Neuroimaging Initiative, 2018 apr, I : Neurobiology of Aging. 64, s. 76-84 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Determining clinically meaningful decline in preclinical Alzheimer disease

    Philip S. Insel, Weiner, M., Mackin, R. S., Mormino, E., Lim, Y. Y., Erik Stomrud, Sebastian Palmqvist, Masters, C. L., Maruff, P. T., Oskar Hansson & Niklas Mattsson, 2019 jul 23, I : Neurology. 93, 4, s. e322-e333

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Lautner, R., Philip S. Insel, Skillbäck, T., Olsson, B., Landén, M., Frisoni, G. B., Herukka, S-K., Hampel, H., Wallin, A., Lennart Minthon, Oskar Hansson, Blennow, K., Niklas Mattsson & Zetterberg, H., 2017 okt 23, I : Alzheimer's Research and Therapy. 9, 1, 87.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa